- Home
- ALZN vs SDOT Comparison
ALZN vs SDOT Comparison
Compare ALZN & SDOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- SDOT
- Stock Information
- Founded
- ALZN 2016
- SDOT 2014
- Country
- ALZN United States
- SDOT United States
- Employees
- ALZN N/A
- SDOT N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- SDOT Restaurants
- Sector
- ALZN Health Care
- SDOT Consumer Discretionary
- Exchange
- ALZN Nasdaq
- SDOT Nasdaq
- Market Cap
- ALZN 7.5M
- SDOT 8.0M
- IPO Year
- ALZN 2021
- SDOT 2020
- Fundamental
- Price
- ALZN $2.32
- SDOT $0.91
- Analyst Decision
- ALZN Strong Buy
- SDOT
- Analyst Count
- ALZN 1
- SDOT 0
- Target Price
- ALZN $45.00
- SDOT N/A
- AVG Volume (30 Days)
- ALZN 71.9K
- SDOT 139.7K
- Earning Date
- ALZN 09-10-2025
- SDOT 08-14-2025
- Dividend Yield
- ALZN N/A
- SDOT N/A
- EPS Growth
- ALZN N/A
- SDOT N/A
- EPS
- ALZN N/A
- SDOT 0.61
- Revenue
- ALZN N/A
- SDOT $667,695,000.00
- Revenue This Year
- ALZN N/A
- SDOT $12.76
- Revenue Next Year
- ALZN N/A
- SDOT $5.54
- P/E Ratio
- ALZN N/A
- SDOT $1.18
- Revenue Growth
- ALZN N/A
- SDOT 7.00
- 52 Week Low
- ALZN $2.06
- SDOT $0.84
- 52 Week High
- ALZN $22.23
- SDOT $5.70
- Technical
- Relative Strength Index (RSI)
- ALZN 40.27
- SDOT 41.60
- Support Level
- ALZN $2.34
- SDOT $0.89
- Resistance Level
- ALZN $2.53
- SDOT $0.95
- Average True Range (ATR)
- ALZN 0.13
- SDOT 0.05
- MACD
- ALZN 0.02
- SDOT 0.01
- Stochastic Oscillator
- ALZN 29.03
- SDOT 50.00
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.